I see china have just put US$1.8 billion into private US biotechnology firms in the three months ended March 31
Beijing seeks to become a global leader in new medicines, adding to a flood of cash flowing to groundbreaking health firms
"china has an insatiable appetite for access to the biotech area"
Add to My Watchlist
What is My Watchlist?
